N/A N=146 Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Scar · Skin Scarring · Skin Cancer
Primary: Cosmetic Outcome — 7.4; 6.6; 6.3; 6.00 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Post Excision/Mohs Scar Laser Resurfacing
Skin Cancer
Primary: MMSS for Scar Halves Treated — 8.4; 8.7 score on a scale
Phase 2 N=22 Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
Scars
Primary: Patient and Observer Scar Assessment Scale (POSAS) - PI Assessment — 4.4; 4.5 score on a scale
N/A N=40 Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars
Hypertrophic Surgical Scar
Primary: Change From Baseline in Vancouver Scar Scale Score(VSS) at 3 Months — -3.80; -2.61 units on a scale
Phase 2 N=100 Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
Reduction of Hypertrophic Skin Scarring
Primary: Physician Global Assessment Using Physician Overall Opinion Question of Patient and Observer Scar Assessment Scale (POSAS) — 4.00; 4.68; 4.61; 4.86 units on scale…
Phase 2 N=12 Study of EB-001 in Facial Scar Reduction
Mohs Surgery
Primary: Assessment of Visual Analog Scale (VAS) Change (Values From 0 (Worst) to 10 (Best)) — 0; 50 Percentage reporting improvement
N/A N=20 Treatment of Post-Surgical Scars With Traditional Ablative Er:YAG Versus Fractional Ablative Er:YAG
Post-Surgical Scars
Primary: Patient Observer Scar Assessment Scale (POSAS) — 17.69; 11.2; 15.2; 11.4 units on a scale — p=0.019
N/A N=6 Laser Resurfacing Versus Dermabrasion for Scar Revision
Cicatrix · Dermabrasion · Coagulation, Laser
Primary: Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing — 1.33; 3.00; 0; 0 units on a scale
Phase 4 N=28 Effect of Collagenase on Healing and Scarring
Scarring · Impaired Wound Healing
Primary: Time to Complete Wound Closure Collagenase Santyl and Vehicle — 12.9; 13.0 Days — p=<0.05
N/A N=60 Timing of Suture Removal to Reduce Scarring in Skin Surgery
Suture Related Complication
Primary: The Measured Difference in POSAS and VAS Scores Between 7-day and 10-day Groups — 12.9; 16.1; 19.5; 20.3 score on a scale
N/A N=51 Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift
Surgical Scar · Breast Augmentation · Abdominoplasty
Primary: Improvement of Surgical Scars at 12 Months Compared to Baseline (Pre-treatment) as Evaluated by 3 Independent Blinded Reviewers Using the General Aesthetic Improvement…
Phase 2 N=60 Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
Fibrosis · Skin Scarring · Skin Wound
Primary: Change in Scar Pliability Between the Treated and Control Incision Sites as Measured by Skin Elasticity at 6 Months Compared to Baseline
N/A N=51 Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy
Cicatrix · Carbon Dioxide Laser
Primary: Change in Vectra Measured Length V1 (Month 0)-V2 (Month 3) for Original Group; Visit 3 (Month 6) to Visit 4 (Month 9) for Crossover Group — 0.10; 0.03 mm
N/A N=41 SkinPen Efficacy on Acne Scars on the Face and/or Back
Atrophic Acne Scar
Primary: Severity of Acne Scars — 3.19; 3.10; 2.81; 2.90 score on a scale — p=<0.008
Phase 2 N=68 Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
Reduction in Hypertrophic Skin Scarring
Primary: Physician Observer Scar Assessment Score at Week 24 — 0.0; -0.5; 0.8; -0.3 units on a scale — p=1.000
N/A N=67 A Study of a Novel Silicone Dressing to Minimize Scar Formation
Hypertrophic
Primary: Visual Analogue Scale (VAS) — 2.90; 3.29 score on a scale
Phase 2 N=30 Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
Scar Prevention
Primary: Part B: Expert Panel Scar Assessment Score — -3.16; 0.18; 1.45; 2.91 millimeters
Phase 2 N=41 Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
Scar Prevention
Primary: Expert Panel Scar Assessment Score at Week 12: Part B — 37.8; 42.1 millimeter — p=0.168
Early Phase 1 N=4 RAPA-Keloid Study of Keloid Regression
Keloid
Primary: Change in Keloid Surface Area — 0.455; -0.039 cm2
Phase 2 N=25 Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
Scar Prevention
Primary: Expert Panel Scar Assessment Score at Week 12 — 36.6; 51.4 millimeter — p=<0.001
N/A N=10 Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Mean Change From Baseline in Erythema — -1.687; 5.730 units on a scale
N/A N=40 Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
Acne · Scars
Primary: Number of Partecipants With Improvement of Acne Scars and Marks and Without New Acne Scars After 4 Weeks — 5 participants
N/A N=29 Fractionated Carbon Dioxide Laser and Burn Scar Contractures: Evaluation of Post-Treatment Scar Function and Appearance
Burn Scars
Primary: Scar Pigmentation, Baseline vs 15-months — 50.93; 49.59 units on a scale